12:00 AM
 | 
Jan 30, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

RotaTeq regulatory update

EMA's CHMP issued a positive opinion to expand the label of RotaTeq to include vaccination of infants ages 6-32 weeks...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >